Liu E - Search Results

1

Current Practices and Novel Techniques in the Diagnosis and Management of Neuroendocrine Tumors of Unknown Primary.

Hendifar AE, Ramirez RA, Anthony LB, Liu E. Hendifar AE, et al. Among authors: liu e. Pancreas. 2019 Oct;48(9):1111-1118. doi: 10.1097/MPA.0000000000001391. Pancreas. 2019. PMID: 31609931 Free PMC article. Review.

2

Consensus guidelines for the management and treatment of neuroendocrine tumors.

Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro K, Chan JA, Chen H, Jensen RT, Kim MK, Klimstra DS, Kulke MH, Liu EH, Metz DC, Phan AT, Sippel RS, Strosberg JR, Yao JC; North American Neuroendocrine Tumor Society. Kunz PL, et al. Pancreas. 2013 May;42(4):557-77. doi: 10.1097/MPA.0b013e31828e34a4. Pancreas. 2013. PMID: 23591432 Free PMC article.

3

The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.

Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, Law CH, Liu EH, Kim MK, Menda Y, Morse BG, Bergsland EK, Strosberg JR, Nakakura EK, Pommier RF. Howe JR, et al. Among authors: liu eh. Pancreas. 2017 Jul;46(6):715-731. doi: 10.1097/MPA.0000000000000846. Pancreas. 2017. PMID: 28609357 Free PMC article. Review.

4

Breakthrough Symptoms Remain an Unmet Need in Symptomatic Patients With Neuroendocrine Tumors and Carcinoid Syndrome.

Liu E, Hoffman KD, Murfin G, Eccard H. Liu E, et al. Pancreas. 2023 Jan 1;52(1):e70-e74. doi: 10.1097/MPA.0000000000002228. Pancreas. 2023. PMID: 37378902

5

Pancreatic Neuroendocrine Tumors and Lymph Nodes: How Much Surgery is Enough?

Liu EH. Liu EH. Ann Surg Oncol. 2024 May;31(5):2809-2810. doi: 10.1245/s10434-024-14946-1. Epub 2024 Jan 27. Ann Surg Oncol. 2024. PMID: 38280958 No abstract available.

6

Assessment of NETest Clinical Utility in a U.S. Registry-Based Study.

Liu E, Paulson S, Gulati A, Freudman J, Grosh W, Kafer S, Wickremesinghe PC, Salem RR, Bodei L. Liu E, et al. Oncologist. 2019 Jun;24(6):783-790. doi: 10.1634/theoncologist.2017-0623. Epub 2018 Aug 29. Oncologist. 2019. PMID: 30158287 Free PMC article.

7

Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study.

Morse MA, Liu E, Joish VN, Huynh L, Cheng M, Duh MS, Seth K, Lapuerta P, Metz DC. Morse MA, et al. Among authors: liu e. Cancer Manag Res. 2020 Jul 30;12:6607-6614. doi: 10.2147/CMAR.S261257. eCollection 2020. Cancer Manag Res. 2020. PMID: 32801896 Free PMC article.

8

Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study.

Paulson S, Ray D, Aranha S, Scales A, Wang Y, Liu E. Paulson S, et al. Among authors: liu e. Oncol Ther. 2022 Dec;10(2):463-479. doi: 10.1007/s40487-022-00208-1. Epub 2022 Sep 22. Oncol Ther. 2022. PMID: 36136274 Free PMC article.

9

Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome.

Metz DC, Liu E, Joish VN, Huynh L, Totev TI, Duh MS, Seth K, Giacalone S, Lapuerta P, Morse MA. Metz DC, et al. Among authors: liu e. Cancer Manag Res. 2020 Oct 7;12:9713-9719. doi: 10.2147/CMAR.S276519. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116830 Free PMC article.

10

Time for a change and to adopt a novel molecular genomic approach in NETs.

Bodei L, Liu E, Paulson S, Gulati A, Freudman J, Grosh W, Kafer S, Wickremesinghe PC, Salem RR. Bodei L, et al. Among authors: liu e. Nat Rev Clin Oncol. 2019 Apr;16(4):269-270. doi: 10.1038/s41571-019-0185-5. Nat Rev Clin Oncol. 2019. PMID: 30809030 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,051 results

Search Page